{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:32:51Z","timestamp":1783567971056,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008741","name":"EULAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clim.2018.12.009","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T04:32:37Z","timestamp":1550118757000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis"],"prefix":"10.1016","volume":"199","author":[{"given":"Corrado","family":"Campochiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lytton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Nihtyanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voon H.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.12.009_bb0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2018.12.009_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7861\/clinmedicine.16-1-55","article-title":"Advances in pathogenesis and treatment of systemic sclerosis","volume":"16","author":"Denton","year":"2016","journal-title":"Clin. Med. (Lond)"},{"key":"10.1016\/j.clim.2018.12.009_bb0015","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2018.12.009_bb0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3899\/jrheum.170055","article-title":"Scleroderma lung involvement, autoantibodies, and outcome prediction: the confounding effect of time","volume":"44","author":"Nihtyanova","year":"2017","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.clim.2018.12.009_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040459","article-title":"A novel serum metabolomics-based diagnostic approach for colorectal cancer","volume":"7","author":"Nishiumi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clim.2018.12.009_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2017.07.060","article-title":"Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform","volume":"491","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.clim.2018.12.009_bb0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.21037\/atm.2017.06.29","article-title":"Neopterin as a biomarker of immune response in cancer patients","volume":"5","author":"Melichar","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.clim.2018.12.009_bb0040","first-page":"383","article-title":"Metabolism of 14C-labelled L-tryptophan, L-kynurenine and hydroxy-L-kynurenine in miners with scleroderma","volume":"51","author":"Hankes","year":"1977","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.clim.2018.12.009_bb0045","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199003293221302","article-title":"Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan","volume":"322","author":"Silver","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2018.12.009_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/pterid-2014-0015","article-title":"Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors","volume":"26","author":"Geisler","year":"2015","journal-title":"Pteridines"},{"key":"10.1016\/j.clim.2018.12.009_bb0055","first-page":"134","article-title":"Tryptophan metabolism \"via\" nicotimic acid in patients with scleroderma","volume":"30","author":"De Antoni","year":"1976","journal-title":"Acta Vitaminol. Enzymol."},{"issue":"1\u20132","key":"10.1016\/j.clim.2018.12.009_bb0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"Schr\u00f6cksnadel","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clim.2018.12.009_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.clim.2018.12.009_bb0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2018.12.009_bb0075","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.12.009_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.clim.2018.12.009_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500845","article-title":"The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment","volume":"1","author":"Sharma","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.clim.2018.12.009_bb0090","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1128\/JVI.00994-16","article-title":"Kynurenine reduces memory CD4 T-cell survival by interfering with interleukin-2 signaling early during HIV-1 infection","volume":"90","author":"Dagenais-Lussier","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2018.12.009_bb0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1006\/cyto.1999.0661","article-title":"Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells","volume":"12","author":"Babcock","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2018.12.009_bb0100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1515\/bchm3.1989.370.2.1063","article-title":"Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells","volume":"370","author":"Werner-Felmayer","year":"1989","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.clim.2018.12.009_bb0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/jid.2013.303","article-title":"Kynurenine increases matrix metalloproteinase-1 and -3 expression in cultured dermal fibroblasts and improves scarring in vivo","volume":"134","author":"Li","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2018.12.009_bb0110","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.4155\/bio.15.175","article-title":"Fast and sensitive HPLC method for the determination of neopterin, kynurenine and tryptophan in amniotic fluid, malignant effusions and wound exudates","volume":"7","author":"Krcmova","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.clim.2018.12.009_bb0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.humimm.2012.11.008","article-title":"Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis","volume":"74","author":"Tardito","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2018.12.009_bb0120","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.clim.2018.12.009_bb0125","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/clinchem\/43.12.2424","article-title":"Simultaneous measurement of serum tryptophan and kynurenine by HPLC","volume":"43","author":"Widner","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clim.2018.12.009_bb0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fimmu.2014.00551","article-title":"Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research","volume":"5","author":"Nguyen","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2018.12.009_bb0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/1547691X.2017.1377323","article-title":"Expression of aryl hydrocarbon receptor, inflammatory cytokines, and incidence of rheumatoid arthritis in Vietnamese dioxin-exposed people","volume":"14","author":"Nguyen","year":"2017","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.clim.2018.12.009_bb0140","first-page":"29","article-title":"Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis","volume":"7","author":"Nguyen","year":"2015","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.clim.2018.12.009_bb0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10067-005-0056-6","article-title":"Tryptophan degradation increases with stage in patients with rheumatoid arthritis","volume":"25","author":"Schroecksnadel","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2018.12.009_bb0150","first-page":"67","article-title":"Exploitation of the IDO pathway in the therapy of rheumatoid arthritis","volume":"6","author":"Williams","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.clim.2018.12.009_bb0155","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2018.12.009_bb0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature13323","article-title":"Aryl hydrocarbon receptor control of a disease tolerance defence pathway","volume":"511","author":"Bessede","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clim.2018.12.009_bb0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bcmd.2007.06.026","article-title":"Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism","volume":"40","author":"Puccetti","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.clim.2018.12.009_bb0170","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","article-title":"Modulation of tryptophan catabolism by regulatory T cells","volume":"4","author":"Fallarino","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2018.12.009_bb0175","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.0806855105","article-title":"Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis","volume":"105","author":"Flores-Borja","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2018.12.009_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.192.2.303","article-title":"Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4","volume":"192","author":"Takahashi","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2018.12.009_bb0185","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ni846","article-title":"CTLA-4-Ig regulates tryptophan catabolism in vivo","volume":"3","author":"Grohmann","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2018.12.009_bb0190","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/art.38715","article-title":"Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway","volume":"66","author":"Cribbs","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.12.009_bb0195","article-title":"Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2018.12.009_bb0200","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/annrheumdis-2016-210503","article-title":"Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)","volume":"76","author":"Herrick","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.12.009_bb0210","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/jcp.25383","article-title":"Kynurenine modulates MMP-1 and type-I collagen expression via aryl hydrocarbon receptor activation in dermal fibroblasts","volume":"231","author":"Poormasjedi-Meibod","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.clim.2018.12.009_bb0215","article-title":"Importance of kynurenine in pulmonary hypertension","volume":"313","author":"Nagy","year":"2017","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.clim.2018.12.009_bb0220","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.12.009_bb0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/138920006778017768","article-title":"Antitumoral activity of interferon involved in impaired immune function in cancer patients","volume":"7","author":"Brandacher","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.clim.2018.12.009_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4137\/IJTR.S38355","article-title":"The kynurenine pathway is a double-edged sword in immune-privileged sites and in cancer: implications for immunotherapy","volume":"9","author":"Routy","year":"2016","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.clim.2018.12.009_bb0235","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri.2016.80","article-title":"Regulatory circuits of T cell function in cancer","volume":"16","author":"Speiser","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2018.12.009_bb0240","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.clim.2018.12.009_bb0245","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4062\/biomolther.2017.194","article-title":"Convergence of Cancer Metabolism and Immunity: an Overview","volume":"26","author":"Dang","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.clim.2018.12.009_bb0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000096906","article-title":"Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients","volume":"214","author":"Weinlich","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.clim.2018.12.009_bb0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-319-67577-0_9","article-title":"Tryptophan catabolism and cancer immunotherapy targeting IDO mediated immune suppression","volume":"1036","author":"Amobi","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.clim.2018.12.009_bb0260","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.21873\/anticanres.11551","article-title":"The kynurenine pathway: a primary resistance mechanism in patients with glioblastoma","volume":"37","author":"Sordillo","year":"2017","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.clim.2018.12.009_bb0265","doi-asserted-by":"crossref","first-page":"461.e15","DOI":"10.1016\/j.urolonc.2017.02.011","article-title":"Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma","volume":"35","author":"Lucarelli","year":"2017","journal-title":"Urol Oncologia"},{"issue":"3","key":"10.1016\/j.clim.2018.12.009_bb0270","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2017.03.120","article-title":"Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma","volume":"486","author":"Cheng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.clim.2018.12.009_bb0275","doi-asserted-by":"crossref","first-page":"32134","DOI":"10.18632\/oncotarget.16739","article-title":"Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618307198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618307198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T18:52:17Z","timestamp":1606503137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618307198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":54,"alternative-id":["S1521661618307198"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.12.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}